摘要
目的探讨康莱特与GP方案联合对晚期非小细胞肺癌患者生存质量的影响。方法选择2013年12月~2015年12月我院肿瘤科收治的晚期非小细胞肺癌患者90例,将其平均分为研究组与对照组。对照组应用GP方案治疗,研究组在对照组的基础上应用康莱特注射液。结果研究组治疗后社会关系、治疗情况、心理情况、精神情况生存质量分值均低于对照组（P〈0.05）。结论在常规GP方案的基础上联合康莱特可以有效提高晚期非小细胞肺癌患者的生存质量。
Objective To study the kanglaite combined with GP scheme on quality of life in advanced non-small cell lung cancer patients. Methods Chose in December 2013 to December 2015 in our oncology treated 90 cases of patients with advanced non-small cell lung cancer,its average can be divided into research group and the control group. The control group,the application of GP regimen for the team in the control group on the basis of application of kanglaite injection. Results The treatment group after the social relations,treatment situation and psychological situation,mental quality of life scores were lower than that of control group（P〈0.05）. Conclusion On the basis of conventional GP scheme combined kanglaite can effectively improve the quality of survival in patients with advanced non-small cell lung cancer.
出处
《中国卫生标准管理》
2016年第10期102-103,共2页
China Health Standard Management
